For those desiring to outshine the market, the strategic selection of individual stocks is paramount. Well-chosen stocks have the potential to substantially boost your wealth.
As of close of business last night, Arcutis Biotherapeutics Inc’s stock clocked out at $14.39, up 6.36% from its previous closing price of $13.53. In other words, the price has increased by $6.36 from its previous closing price. On the day, 2.28 million shares were traded.
Ratios:
To gain a deeper understanding of ARQT’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 3.37 and its Current Ratio is at 3.55. In the meantime, Its Debt-to-Equity ratio is 0.78 whereas as Long-Term Debt/Eq ratio is at 0.77.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, H.C. Wainwright on December 30, 2024, initiated with a Buy rating and assigned the stock a target price of $19.
On August 28, 2024, Jefferies started tracking the stock assigning a Buy rating and target price of $15.
Mizuho Upgraded its Neutral to Buy on January 03, 2024, whereas the target price for the stock was revised from $4 to $8.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on May 08 ’25 when Burnett Patrick sold 3,871 shares for $13.59 per share. The transaction valued at 52,623 led to the insider holds 115,468 shares of the business.
Burnett Patrick bought 3,871 shares of ARQT for $52,623 on May 08 ’25. On May 02 ’25, another insider, Matsuda Masaru, who serves as the insider of the company, sold 5,030 shares for $15.20 each. As a result, the insider received 76,453 and left with 204,399 shares of the company.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 8.06 while its Price-to-Book (P/B) ratio in mrq is 12.02.
Stock Price History:
Over the past 52 weeks, ARQT has reached a high of $17.75, while it has fallen to a 52-week low of $6.99. The 50-Day Moving Average of the stock is -2.58%, while the 200-Day Moving Average is calculated to be 18.96%.
Shares Statistics:
A total of 119.14M shares are outstanding, with a floating share count of 104.87M. Insiders hold about 12.03% of the company’s shares, while institutions hold 101.80% stake in the company.
